https://www.freenome.com | United States | 2014 | $1099.05M
Freenome is an AI genomics biotechnology company based in South San Francisco, California that is developing blood tests for the early detection of cancer. The company has leveraged its multiomics platform to create screening tests for colorectal and lung cancer. Freenome has large-scale registrational studies underway and multi-cancer research programs to validate its blood-based early detection tests. The company recently raised $254 million in new funding from investors like Roche to advance its pipeline and expand its platform capabilities.
